293 related articles for article (PubMed ID: 11115082)
21. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
22. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
23. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
Stigant CE; Cohen J; Vivera M; Zaltzman JS
Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
[TBL] [Abstract][Full Text] [Related]
24. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
26. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
Horita Y; Tadokoro M; Taura K; Suyama N; Taguchi T; Miyazaki M; Kohno S
Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
28. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
Horita Y; Taura K; Taguchi T; Furusu A; Kohno S
Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II local hyperreactivity in the progression of IgA nephropathy.
Coppo R; Amore A; Gianoglio B; Cacace G; Picciotto G; Roccatello D; Peruzzi L; Piccoli G; De Filippi PG
Am J Kidney Dis; 1993 Jun; 21(6):593-602. PubMed ID: 8503412
[TBL] [Abstract][Full Text] [Related]
31. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
32. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
Cheng J; Zhang W; Zhang XH; He Q; Tao XJ; Chen JH
Int J Clin Pract; 2009 Jun; 63(6):880-8. PubMed ID: 19490198
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
34. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
[TBL] [Abstract][Full Text] [Related]
35. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.
Praga M; Gutiérrez E; González E; Morales E; Hernández E
J Am Soc Nephrol; 2003 Jun; 14(6):1578-83. PubMed ID: 12761258
[TBL] [Abstract][Full Text] [Related]
36. [Clinical effects of trandolapril in chronic glomerulonephritis patients with renal insufficiency].
Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
Nihon Jinzo Gakkai Shi; 2000 May; 42(4):333-7. PubMed ID: 10897592
[TBL] [Abstract][Full Text] [Related]
37. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
38. Comparison of histopathological characteristics of allograft biopsy between responder and non-responder to antiproteinuric effect of angiotensin-converting enzyme inhibitor (ACEI).
Namba Y; Moriyama T; Kyo M; Oka K; Kokado Y; Shi Y; Imamura R; Ichimaru N; Okuyama A; Takahara S
Clin Transplant; 2004; 18 Suppl 11():29-33. PubMed ID: 15191370
[TBL] [Abstract][Full Text] [Related]
39. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
40. Statins stabilize the renal function of IgA nephropathy.
Moriyama T; Oshima Y; Tanaka K; Iwasaki C; Ochi A; Itabashi M; Takei T; Uchida K; Nitta K
Ren Fail; 2014 Apr; 36(3):356-60. PubMed ID: 24341619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
